Integrated IPG Combining Cardiac Contractility Modulation and Defibrillation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current implantable pulse generators (IPGs) require multiple devices for various cardiac treatments, such as Cardiac Contractility Modulation, Cardioversion, Defibrillation, and Cardiac Resynchronization Therapy, which can be cumbersome and inefficient, lacking the ability to automatically adjust treatment modalities based on clinical benefits.

Innovation Solution

An integrated IPG device with Cardiac Contractility Modulation, Cardioversion, Defibrillation, and Cardiac Resynchronization Therapy capabilities, featuring a controller that evaluates cardiac data to determine clinical benefits and automatically selects or adjusts treatment modalities, including combinations of therapies, based on patient-specific parameters.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If multiple separate IPG devices are used for different cardiac treatments, then each device can be optimized for its specific function, but the overall system complexity increases and patient management becomes cumbersome

Engineering Contradiction:
Improvefunctional optimizationVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent combines multiple cardiac treatment modalities (Cardiac Contractility Modulation, Cardioversion, Defibrillation, Cardiac Pacing, and Cardiac Resynchronization Therapy) into a single integrated IPG device. This merging approach maintains functional optimization for each modality while reducing the number of separate devices from five to one, thereby decreasing system complexity and improving patient management.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The integrated IPG device is designed to provide universal cardiac treatment capabilities across multiple modalities within a single device platform. The controller can automatically select and switch between different treatment types based on clinical needs, making the device universally applicable for various cardiac conditions without requiring separate specialized devices.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Device complexity

If a single integrated IPG device provides multiple treatment modalities, then device complexity is reduced and patient management is simplified, but the ability to automatically adjust treatment based on clinical benefits is lost

Engineering Contradiction:
Improvesystem complexityVSAvoidautomatic treatment adjustment
Core Design Contradiction:
Device complexityVSExtent of automation

Solution Approach 1:

The integrated IPG device incorporates a controller that automatically gathers cardiac data, evaluates the clinical benefit of different treatment modalities by comparing cardiac parameters to reference data, and adjusts treatment selection accordingly. This feedback mechanism enables automatic treatment optimization while maintaining the benefits of a single integrated device, resolving the contradiction between device simplicity and automated adaptability.

Inventive Principle:
Principle #23Feedback

3Reliability

If treatment modalities are manually selected and adjusted, then clinical expertise is applied, but time is lost and productivity decreases

Engineering Contradiction:
Improveclinical judgmentVSAvoidtreatment adjustment efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The controller in the integrated IPG device performs self-service by automatically evaluating cardiac data, determining clinical benefit, and selecting appropriate treatment modalities without requiring manual intervention. This automation maintains reliable clinical decision-making through embedded algorithms while significantly improving treatment adjustment efficiency and reducing the time required for therapy optimization.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS20240100349A1Combined implantable pulse generator device
Publication Date: 2024.03.28 IMPULSE DYNAMICS NV
  • US20240100349A1 patent drawing
  • US20240100349A1 patent drawing
  • US20240100349A1 patent drawing

AI summary

A method of treating a heart, the method including providing an Implantable Pulse Generator (IPG) adapted to provide a combination of at least two treatment modalities including Cardiac Contractility Modulation therapy and one more modality selected from a group consisting of Cardiac pacing, Cardioversion, Defibrillation, Cardioversion and Defibrillation, and Cardiac Resynchronization Therapy (CRT), detecting a patient's physical condition, and selecting a combination of Cardiac Contractility Modulation therapy and at least one treatment modality from the group, and providing the combination of the Cardiac Contractility Modulation therapy and the at least one treatment modality. Related apparatus and methods are also described.